Category: hemophilia
Precision Public Health in Action: Enhancing models to predict risk of adverse treatment outcomes in people with hemophilia
In collaboration with the CDC Office of Advanced Molecular Detection, the Office of Genomics and Precision Public Health recently funded the National Center on Birth Defects and Developmental Disabilities (NCBDDD) to strengthen public health capacity by introducing elements of human genomics into applied research on predicting inhibitor risk in people with hemophilia. Hemophilia refers to a group Read More >
Posted on byCategories genomics